Personalised Exercise Training in COPD

September 7, 2020 updated by: Dr Tom Ward, Loughborough University

Personalised Exercise Training in COPD - Exploring the Interaction Between Exercise Physiology, Exercise Perception and Training Progression

Exercise training as part of Pulmonary Rehabilitation (PR) has been shown conclusively to improve breathlessness,quality of life and exercise capacity for people with COPD. However generally PR is delivered in a 'one size fits all' approach without considering different aspects of an individual's disease. It is hypothesised that a more personalised approach to PR may yield even better results. However to design a personalised programme of PR we need a better understanding of how different people with COPD respond to different possible exercise training modalities. This study will therefore comprehensively characterise a group of patients and then ask them to complete 3 weeks of exercise training in one of four modalities; conventional cycling, eccentric cycling, one-legged cycling and resistance training. The aim is not to prove which type of training is more effective but to develop an idea of which groups of patients would benefit from which type of training.

Baseline measures would be designed to fully understand how an individual responds to exercise and would therefore be comprised of a variety of endurance tests, strength tests, questionnaires, and measurements of lung capacity and body composition. This is to give as much information as possible to identify different responses to exercise.

Study Overview

Status

Completed

Conditions

Detailed Description

Chronic obstructive pulmonary disease (COPD) is a highly prevalent condition affecting an estimated 1.2 million people in the UK and is the second most common lung disease after asthma. COPD not only affect the lungs, but is a systemic disease with muscle dysfunction being a significant feature. Exercise, as part of a programme of pulmonary rehabilitation (PR), has been shown to improve exercise capacity and quality of life of patients with COPD. However, despite the effectiveness of PR at a population level, there remains room for improvement. The individual treatment response is heterogeneous with some patients failing to achieve clinically significant improvements, whilst others struggle to adhere to the exercise component or drop out altogether. Currently, whilst exercise intensities (the "dose") are individualised during PR, the character and content of PR is generally provided in a "one size fits all" manner. There is therefore scope to modify the content of PR to meet individual needs and underlying physiology thereby enhancing adherence and benefits.

Precision medicine, tailoring therapy to specific "treatable traits" of an individual's condition, holds the potential to maximise treatment effect whilst minimising adverse effects. The investigators propose the same principles of precision medicine can be used to improve the delivery of PR by identifying an individual's exercise response at enrolment to PR and using this information to personalise exercise training. There are a growing number of diverse, novel training modalities that have been shown to be feasible and potentially efficacious in COPD, offering opportunities for delivering a personalised training programme. A key step in the development of this personalised/precision approach in exercise medicine is the understanding and measurement of the individual exercise pathophysiology that predicts preferential benefits to a particular exercise training modality. However, the relationship between baseline exercise pathophysiology (and indeed other disease and demographic variables) and such a response is currently unknown.

Eccentric exercise, contraction of a muscle as it lengthens, and one-legged cycling are two options for diversifying PR. For a given muscle workload, eccentric exercise results in lower energy demand and oxygen consumption and therefore puts less strain on the cardiopulmonary system. Consequently, this type of exercise may be ideally suited for patients with lung disease, particularly for those who stop exercise due to ventilatory limitations. It may be more tolerable for patients as it causes less breathlessness, whilst allowing greater muscle specific work. Eccentric cycling involves use of a bike with an attached motor which drives the pedals in reverse. The subject must resist the rotation of the pedals to maintain a constant pedal speed, thereby performing eccentric work with their legs. Using eccentric exercise as a training modality had historically been avoided due to the fear of causing muscle damage. High intensity eccentric resistance exercise leads to delayed onset muscle soreness (DOMS) and has been used for many years as a model of inducing muscle damage. However over the last 30 years there have been an increasing number of studies showing comprehensively that if load is gradually increased, muscle damage and soreness is minimal and acceptable. In patient populations, because loads achieved are particularly low, the occurrence of significant muscle damage is even more infrequent and previous work, has demonstrated that eccentric cycling is well tolerated in patients with COPD.

Whole body exercise, such as walking or cycling, requires recruitment of a large muscle mass generating a high oxygen demand. However, there is a disparity between whole body maximal oxygen uptake and muscle maximum aerobic capacity, even in a healthy population, and consequently significant variation in the muscle training stimuli achieved. This is emphasised in patients with COPD with a ventilatory limit to exercise. By exercising a smaller muscle mass, this ventilatory limitation can be bypassed and the individual muscle can be worked at significantly higher intensity. One method to reduce the exercising muscle mass is one-legged cycling. Two randomised controlled trials have demonstrated a greater improvement in V̇O2peak following one-legged cycling compared with two legged cycling in patients with COPD. One-legged cycling has been demonstrated to be a feasible addition to a PR programme and well received by patients and physiotherapists.

This study aims to determine how disease, demographic and exercise physiological variables recorded at baseline relate to subsequent perception and progression of novel training modalities compared to conventional training. The investigators will perform a comprehensive assessment of physiological response to exercise at baseline in terms of exercise capacity, exercise limitation, muscle volume and strength, physical activity, frailty and muscle composition. Participants will then be randomly allocated to one of 4 training modalities; eccentric cycling, one-legged cycling, concentric (traditional 2-legged cycling), or lower limb resistance training.

This is a pilot/feasibility study with the broad aim of identifying potential subphenotypes of patients with COPD that might respond preferentially to particular modalities of training. This knowledge is crucial to the development of definitive clinical trials of such exercise medicine interventions that could be delivered in routine clinical practice. The specific aims are:

  1. To characterise in detail the underlying pulmonary and systemic pathophysiological characteristics of patients with COPD who are disabled by exercise limitation.
  2. To measure progression of training loads during each training intervention relative to baseline values.
  3. To determine how baseline characteristics and pathophysiology relate to training progression and exercise experience.

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Loughborough, United Kingdom, LE11 3TU
        • Loughborough University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male or Female, aged 40 years or above
  • Diagnosis of COPD
  • FEV1/FVC <0.7 and FEV1 < 80% predicted
  • Medical Research Council (MRC) dyspnoea scale ≥3
  • Participant is willing and able to give informed consent for participation in the study.
  • Stable dose of current regular medication for at least 4 weeks prior to study entry.
  • Participant has clinically acceptable ECG at enrolment.
  • Able (in the Investigators opinion) and willing to comply with all study requirements.
  • English speaking

Exclusion Criteria:

  • Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.
  • Any major or uncontrolled comorbidity that would impair the participant's ability to exercise or would mean exercise was unsafe.
  • Participants who have participated in another research study involving an investigational product in the past 12 weeks
  • Participation in pulmonary rehabilitation in the preceding 6 months
  • Participation in another research study involving exercise training in the preceding 6 months
  • Acute exacerbation in the preceding 4 weeks (would become eligible 4 weeks following recovery)
  • Scheduled elective surgery or other procedures requiring general anaesthesia during the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Eccentric cycling
As above
Active Comparator: Concentric cycling
As above
Active Comparator: Single leg cycling
As above
Active Comparator: Lower limb resistance training
As above

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Training Progression (Total work during training relative to baseline)
Time Frame: 3 weeks
(Total load during training in kJ or kg depending on exercise modality)/(load performed at baseline). This will therefore be presented as a standardised proportion (%) with no unit of measurement. Load refers to the total force production during exercise. For 2 leg and 1 leg concentric cycling and eccentric cycling this refers power output of the ergometer - total energy produced. For resistance exercise this refers to total weight lifted during training (in kg), i.e. weight lifted multiplied by number of repetitions.
3 weeks
Training adherence
Time Frame: 3 weeks
(percentage of training sessions attended)
3 weeks
Subjective exercise experience scale during each exercise modality
Time Frame: Week 2
Validated 12 point questionnaire with each question scoring from 1 (not at all) to 7(very much so). 3 domains - fatigue (high score=high fatigue), positive well-being (high score=high positive well being) and psychological distress (high score=high distress). Each domain represents 4 questions and the score for each domain (from 4-28) will be presented. Completed during all 4 exercise modalities (eccentric cycling, resistance training, single leg cycling and concentric cycling) for each participant
Week 2

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Experience of different exercise modalities - Qualitative questionnaire
Time Frame: 3 weeks
Structured questionnaire tailored to this study requiring short answers. Exploring preference and experience of each training modality. Note: This is not a scale questionnaire, but a short answer questionnaire with results presented as 'themes'
3 weeks
Exercise capacity - peak V̇O2 during a maximal incremental 2 leg cycle test
Time Frame: Baseline
ml.min-1
Baseline
Exercise capacity - peak V̇O2 during a maximal incremental 1 leg cycle test
Time Frame: Baseline
ml.min-1
Baseline
Inspiratory capacity during maximal 2 leg cycling
Time Frame: Baseline
change from baseline (ml)
Baseline
Functional capacity - constant work rate cycling test
Time Frame: Baseline
Performed at 75% of maximum achieved power during two legged maximal incremental cycle test. Participants will be asked to cycle at a constant power output until volitional exhaustion. Outcome will be time (mins)
Baseline
Functional capacity - measured by Timed up-and-go test
Time Frame: Baseline
Time (secs) taken to get up from a chair, walk 3m, return to the chair and sit down.
Baseline
Muscle strength - maximal concentric quadriceps strength
Time Frame: Baseline
Isokinetic knee flexion/extension using dynamometry. Peak torque (Nm) and angle of peak torque recorded
Baseline
Muscle strength - maximal eccentric quadriceps strength
Time Frame: Baseline
Isokinetic knee flexion/extension using dynamometry. Peak torque (Nm) and angle of peak torque recorded
Baseline
Muscle strength - 10 rep max Leg extension
Time Frame: Baseline
Maximum load that participants can lift with two legs for 10 repetitions (kg)
Baseline
Health related quality of life - St George's respiratory questionnaire
Time Frame: Baseline
50 item questionnaire to measure health status (quality of life) in patients with diseases of airways obstruction. Scores are calculated for three domains: Symptoms, Activity and Impacts (Psycho-social) as well as a total score (from 0-100). The minimum change score of 4 units is established as clinically relevant.
Baseline
Frailty - Groningen Frailty Index
Time Frame: Baseline
total score out of 15. A score of 4 of more indicates moderate to severe frailty
Baseline
Balance - Activities specific balance scale (ABC scale)
Time Frame: Baseline
16 item score (each point answered from 0-10 with 0 representing no confidence and 100 representing complete confidence with performing specified activity without loosing balance). Total score given as an average of all questions (presented as a percentage from 0-100%). Lower scores represent worse balance
Baseline
Physical activity - 7-day activity monitor
Time Frame: Baseline
Percentage of time in light and moderate-to-vigorous physical activity
Baseline
Muscle architectural measures seen on muscle biopsy
Time Frame: Baseline
Fibre type composition - percentage of type 1 and type 2 muscle fibres
Baseline
Muscle architectural measures seen on muscle biopsy
Time Frame: Baseline
Fibre size - mean fibre cross sectional area (micrometer2)
Baseline
Capillary density on muscle biopsy
Time Frame: Baseline
Number of capillaries per mm2
Baseline
Body composition - bioelectrical impedance
Time Frame: Baseline
fat free mass index (kg/m2)
Baseline
Breathlessness during exercise - Multidimensional dyspnoea profile
Time Frame: Baseline
Validated questionnaire exploring multiple aspects of dyspnoea. Recorded at baseline and during each of 4 exercise modalities (eccentric cycling, concentric cycling, single leg cycling and lower limb resistance training). Pooled results of each question will be presented. This is not a traditional 'scale' with a 'total score' but produces a multidimensional picture of breathlessness and has been well described in breathlessness research. It is being used as a way to categorise breathlessness response or phenotype.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 3, 2018

Primary Completion (Actual)

August 2, 2019

Study Completion (Actual)

August 2, 2019

Study Registration Dates

First Submitted

October 2, 2018

First Submitted That Met QC Criteria

January 24, 2019

First Posted (Actual)

January 25, 2019

Study Record Updates

Last Update Posted (Actual)

September 9, 2020

Last Update Submitted That Met QC Criteria

September 7, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • IRAS 243125

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COPD

Clinical Trials on Comparison of exercise training modalities

3
Subscribe